Last week Barchester Healthcare announced that it would be acquiring 24 brighterkind care homes in what may be one of the largest care home deals since HC-One’s purchase of 122 care homes from Bupa in 2017. Few care home transactions are large enough to give rise to competition-related concerns, and Barchester’s acquisition provides a good…
Guides, White Papers & Research
Buy-and-Build Strategies: Managing the risk of UK Competition and Markets Authority intervention
This paper draws on our experience as former competition regulators, and our research on buy-and-builds, to identify opportunities that can mitigate the risk of CMA intervention for these platforms.
It contains practical advice around:
- The likelihood of deals being called-in by the CMA
- Influencing the CMA’s view of a market
- How to best engage with the CMA
- Drivers of CMA review costs
Fill in your details to receive your copy:
We will never share your details with anyone.